Raasi Refractories Limited (BOM:502271)
22.50
0.00 (0.00%)
At close: Jan 19, 2026
Raasi Refractories Revenue
Raasi Refractories had revenue of 108.42M INR in the quarter ending June 30, 2025, with 10.74% growth. This brings the company's revenue in the last twelve months to 367.71M, down -23.04% year-over-year. In the fiscal year ending March 31, 2025, Raasi Refractories had annual revenue of 357.19M, down -11.43%.
Revenue (ttm)
367.71M
Revenue Growth
-23.04%
P/S Ratio
0.29
Revenue / Employee
183.86M
Employees
2
Market Cap
106.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 357.19M | -46.11M | -11.43% |
| Mar 31, 2024 | 403.30M | -187.35M | -31.72% |
| Mar 31, 2023 | 590.65M | -38.28M | -6.09% |
| Mar 31, 2022 | 628.93M | 419.85M | 200.81% |
| Mar 31, 2021 | 209.08M | -273.08M | -56.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Santosh Fine Fab | 182.03M |
| Indo Euro Indchem | 123.91M |
| Gian Life Care | 55.16M |
| RCI Industries & Technologies | 41.97M |
| Prism Medico and Pharmacy | 23.72M |
| Galada Finance | 14.40M |
| RLF Limited | 12.59M |
| Ortin Global | 1.74M |